Table 1.
Baseline characteristics of the participants.
| Characteristic | L-VA (n=55) |
H-VA (n=55) |
P value |
|---|---|---|---|
| Age (years, mean±SD) | 41.1±12.1 | 40.1±13.1 | 0.7 |
| Range | 20-69 | 20-68 | |
| Sex (male/female) | 22/33 | 27/28 | 0.337 |
| BMI (kg/m2, mean±SD) | 22.9±3.4 | 22.0±4.0 | 0.211 |
| Range | 16.9-32.2 | 16.4-33.1 | |
| Education status | 0.848 | ||
| High school or less | 24 (43.6%) | 25 (45.5%) | |
| College or more | 31 (56.4%) | 30 (54.5%) | |
| Cigarette smoking | 8 (14.5%) | 10 (18.2%) | 0.606 |
| Alcohol drinking | 18 (32.7%) | 18 (32.7%) | 1 |
| Indications | |||
| Peptic ulcers | 6 (10.9%) | 5 (9.1%) | 0.466 |
| Dyspepsia | 2 (3.6%) | 6 (10.9%) | |
| Gastritis | 20 (36.4%) | 16 (29.1%) | |
| H. pylori confirmed | 27 (49.1%) | 28 (50.9%) | |
BMI, body mass index; L-VA, dual therapy consisting of low-dose amoxicillin (1000 mg b.i.d.) and vonoprazan (20 mg b.i.d.); H-VA, Dual therapy consisting of high-dose amoxicillin (1000 mg t.i.d.) and vonoprazan (20 mg b.i.d.).